Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
BCAR1 | CRKL | CRKL: Crk-like protein | 2.01E3 | Evidence | O | ||||
BCAR1 | GRAP | GRAP: GRB2-related adapter protein | 297.0 | Evidence | |||||
BCAR1 | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 250.0 | Evidence | |||||
BCAR1 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 19.10 | Evidence | |||||
BCAR1 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 19.10 | Evidence | O | ||||
BCAR1 | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 19.10 | Evidence | |||||
BCAR1 | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 10.50 | Evidence | |||||
BCAR1 | INSR | INSR: Insulin receptor precursor | 10.50 | Evidence | |||||
BCAR1 | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 10.50 | Evidence | |||||
BCAR1 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 10.50 | Evidence | |||||
BCAR1 | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 10.50 | Evidence | |||||
BCAR1 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 10.50 | Evidence | |||||
BCAR1 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 10.50 | Evidence | |||||
BCAR1 | WASPIP | N/A | 10.50 | Evidence | |||||
BCAR1 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 10.50 | Evidence | |||||
BCAR1 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 10.50 | Evidence | |||||
BCAR1 | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 7.14 | Evidence | |||||
BCAR1 | SOS1 | SOS1: Son of sevenless homolog 1 | 6.39 | Evidence | |||||
BCAR1 | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 6.39 | Evidence | |||||
BCAR1 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 6.39 | Evidence | |||||
BCAR1 | DOK1 | DOK1: Docking protein 1 | 6.39 | Evidence | |||||
BCAR1 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 6.39 | Evidence | |||||
BCAR1 | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 6.14 | Evidence | |||||
BCAR1 | FASLG | FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 | 6.14 | Evidence | |||||
BCAR1 | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 6.14 | Evidence | |||||
BCAR1 | CD4 | CD4: T-cell surface glycoprotein CD4 precursor | 6.14 | Evidence | |||||
BCAR1 | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 6.14 | Evidence | |||||
BCAR1 | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 6.14 | Evidence | |||||
BCAR1 | EPOR | EPOR: Erythropoietin receptor precursor | 6.14 | Evidence | |||||
BCAR1 | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 6.14 | Evidence | |||||
BCAR1 | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 6.14 | Evidence | |||||
BCAR1 | SLAMF1 | SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor | 6.14 | Evidence | |||||
BCAR1 | LNK | SH2B3, LNK: SH2B adapter protein 3 | 6.14 | Evidence | |||||
BCAR1 | HLA-A | HLA-A, HLAA: HLA class I histocompatibility antigen, A-68 alpha chain precursor | 6.14 | Evidence | |||||
BCAR1 | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 6.14 | Evidence | |||||
BCAR1 | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 6.14 | Evidence | |||||
BCAR1 | MAG | MAG, GMA: Myelin-associated glycoprotein precursor | 6.14 | Evidence | |||||
BCAR1 | GRB10 | N/A | 6.14 | Evidence | |||||
BCAR1 | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 6.14 | Evidence | |||||
BCAR1 | LYN | LYN: Tyrosine-protein kinase Lyn | 6.14 | Evidence | |||||
BCAR1 | IRS1 | IRS1: Insulin receptor substrate 1 | 6.14 | Evidence | |||||
BCAR1 | ADAM15 | ADAM15, MDC15: ADAM 15 precursor | 6.14 | Evidence | |||||
BCAR1 | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 6.14 | Evidence | |||||
BCAR1 | THY1 | THY1: Thy-1 membrane glycoprotein precursor | 6.14 | Evidence | |||||
BCAR1 | ITGB4 | N/A | 6.14 | Evidence | |||||
BCAR1 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 6.14 | Evidence | |||||
BCAR1 | CD79A | CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain | 6.14 | Evidence | |||||
BCAR1 | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 6.14 | Evidence | |||||
BCAR1 | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 6.14 | Evidence | |||||
BCAR1 | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 6.14 | Evidence | |||||
BCAR1 | GAB1 | GAB1: GRB2-associated-binding protein 1 | 6.14 | Evidence | |||||
BCAR1 | TRPV4 | TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb | 6.14 | Evidence | |||||
BCAR1 | NCAM1 | NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor | 6.14 | Evidence | |||||
BCAR1 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 5.50 | Evidence | |||||
BCAR1 | EPHA4 | EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor | 5.50 | Evidence | |||||
BCAR1 | RPS6KB1 | N/A | 5.50 | Evidence | |||||
BCAR1 | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 5.50 | Evidence | |||||
BCAR1 | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 5.50 | Evidence | |||||
BCAR1 | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 5.50 | Evidence | |||||
BCAR1 | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 5.50 | Evidence | O | ||||
BCAR1 | APS | SH2B2, APS: SH2B adapter protein 2 | 5.50 | Evidence | |||||
BCAR1 | VAV1 | VAV1, VAV: Proto-oncogene vav | 5.50 | Evidence | |||||
BCAR1 | EPHA8 | EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor | 5.50 | Evidence | |||||
BCAR1 | CNTN1 | CNTN1: Contactin-1 precursor | 5.50 | Evidence | |||||
BCAR1 | PAK4 | PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 | 5.50 | Evidence | |||||
BCAR1 | CSK | CSK: Tyrosine-protein kinase CSK | 5.50 | Evidence | |||||
BCAR1 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 5.50 | Evidence | |||||
BCAR1 | PLD2 | PLD2: Phospholipase D2 | 5.50 | Evidence | |||||
BCAR1 | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 5.50 | Evidence | |||||
BCAR1 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 5.50 | Evidence | |||||
BCAR1 | DAB1 | DAB1: Disabled homolog 1 | 5.50 | Evidence | |||||
BCAR1 | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 5.50 | Evidence | |||||
BCAR1 | SYK | SYK: Tyrosine-protein kinase SYK | 5.50 | Evidence | |||||
BCAR1 | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 5.50 | Evidence | |||||
BCAR1 | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 5.50 | Evidence | |||||
BCAR1 | FLT4 | VEGFR3 long form | 5.50 | Evidence | |||||
BCAR1 | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 5.50 | Evidence | |||||
BCAR1 | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 5.50 | Evidence | |||||
BCAR1 | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 5.50 | Evidence | |||||
BCAR1 | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 5.50 | Evidence | |||||
BCAR1 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 5.50 | Evidence | |||||
BCAR1 | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 4.68 | Evidence | |||||
BCAR1 | STAT3 | 4.68 | Evidence | ||||||
BCAR1 | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 4.68 | Evidence | |||||
BCAR1 | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 4.68 | Evidence | |||||
BCAR1 | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 4.19 | Evidence | |||||
BCAR1 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 4.19 | Evidence | |||||
BCAR1 | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 4.19 | Evidence | |||||
BCAR1 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 4.19 | Evidence | |||||
BCAR1 | SNX2 | SNX2, TRG9: Sorting nexin-2 | 3.04 | Evidence | |||||
BCAR1 | CNN1 | CNN1: Calponin-1 | 3.04 | Evidence | |||||
BCAR1 | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 2.72 | Evidence | |||||
BCAR1 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 2.72 | Evidence | |||||
BCAR1 | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 2.62 | Evidence | |||||
BCAR1 | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 2.62 | Evidence | |||||
BCAR1 | PLAUR | PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor | 2.62 | Evidence | |||||
BCAR1 | MS4A1 | MS4A1, CD20: B-lymphocyte antigen CD20 | 2.62 | Evidence | |||||
BCAR1 | CNN3 | CNN3: Calponin-3 | 2.62 | Evidence | |||||
BCAR1 | CD5 | CD5, LEU1: T-cell surface glycoprotein CD5 precursor | 2.62 | Evidence | |||||
BCAR1 | CSH2 | GH1: Somatotropin precursor | 2.62 | Evidence | |||||
BCAR1 | CAV1 | CAV1, CAV: Caveolin-1 | 2.34 | Evidence | |||||
BCAR1 | WEE1 | WEE1: Wee1-like protein kinase | 2.34 | Evidence | |||||
BCAR1 | GRIN2B | GRIN2B, NMDAR2B: Glutamate [NMDA] receptor subunit epsilon-2 precursor | 2.34 | Evidence | |||||
BCAR1 | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 2.34 | Evidence | |||||
BCAR1 | H2-ALPHA | TUBA3C, TUBA2, TUBA3D: Tubulin alpha-3C/D chain | 2.34 | Evidence | |||||
BCAR1 | NMT1 | NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 | 2.34 | Evidence | |||||
BCAR1 | IQGAP2 | IQGAP2: Ras GTPase-activating-like protein IQGAP2 | 2.34 | Evidence | |||||
BCAR1 | ATP2A2 | ATP2A2, ATP2B: Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 2.34 | Evidence | |||||
BCAR1 | CDK5 | CDK5: Cell division protein kinase 5 | 2.34 | Evidence | |||||
BCAR1 | CD2AP | CD2AP: CD2-associated protein | 2.34 | Evidence | O | ||||
BCAR1 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 2.34 | Evidence | |||||
BCAR1 | GRIN2A | GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor | 2.34 | Evidence | |||||
BCAR1 | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 2.34 | Evidence | |||||
BCAR1 | CD36 | CD36, GP3B, GP4: Platelet glycoprotein 4 | 2.34 | Evidence | |||||
BCAR1 | K-ALPHA-1 | TUBA1B: Tubulin alpha-1B chain | 2.34 | Evidence | |||||
BCAR1 | CDC7 | CDC7, CDC7L1: Cell division cycle 7-related protein kinase | 2.34 | Evidence | |||||
BCAR1 | MOS | MOS: Proto-oncogene serine/threonine-protein kinase mos | 2.34 | Evidence | |||||
BCAR1 | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 2.34 | Evidence | |||||
BCAR1 | CTTN | CTTN, EMS1: Src substrate cortactin | 1.99 | Evidence | |||||
BCAR1 | CDC2 | CDC2: Cell division control protein 2 homolog | 1.99 | Evidence | |||||
BCAR1 | SMAD3 | SMAD3, MADH3: Mothers against decapentaplegic homolog 3 | 1.81 | Evidence | |||||
BCAR1 | TOM1L1 | TOM1L1, SRCASM: TOM1-like protein 1 | 1.35 | Evidence | |||||
BCAR1 | KCNJ3 | KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 | 1.16 | Evidence | |||||
BCAR1 | CD44 | N/A | 1.16 | Evidence | |||||
BCAR1 | BCAR3 | BCAR3, NSP2, UNQ271/PRO308, SH2D3B: Breast cancer anti-estrogen resistance prote | 1.07 | Evidence | |||||
BCAR1 | SMAD9 | SMAD9, MADH6, MADH9: Mothers against decapentaplegic homolog 9 | 1.07 | Evidence |